An observational study in Silent; Thrombosis, sponsored by Assiut University. Status unknown. Open to female participants. Per ClinicalTrials.gov, last updated 2017-08-24.
Sponsored by Assiut University · Observational
Venous thromboembolism (VTE) is a serious preventable complication of gynecological surgery. High incidence of silent VTE before surgery seems attributable to the high incidence of VTE after surgery in ovarian cancer .so the aim of work is to detect silent venous thrombosis in gynecological patients suffering from pelvic masses using different imaging modalities .
High incidence of silent VTE before surgery seems attributable to the high incidence of VTE after surgery in ovarian cancer .
The incidence rate of DVT is about 10% to 40% in medical or general surgical patients without prophylaxis .With prophylaxis, the postoperative incidence of VTE was 1.14% in women with gynecological disease, and 0.7% in patients undergoing laparoscopic gynecological surgery, 0.3% in patients undergoing urogynecological surgery, and 4% in gynecological cancer patients, respectively. Most of published studies enrolled only symptomatic patients with DVT, whereas asymptomatic patients could be easily neglected under the absence of effective detection. In fact, approximately 50% of DVT patients are silent, so the actual incidence of postoperative DVT might be higher than reported . The asymptomatic DVT has been confirmed to increase the development of post-thrombotic syndrome (PTS).
The essence of any surveillance strategy would be the identification of DVT in the expectation that anticoagulation at the presymptomatic stage would prevent fatal pulmonary embolism .
A number of imaging modalities are currently available to evaluate deep venous system in a comprehensive manner allowing correct assessment of presence of thrombosis . Color Doppler ultrasound has become the primary non invasive diagnostic method for DVT.
All patients are going to be examined by color Doppler ultrasound and by direct MDCT venography .
1,528 studies on the registry are indexed under Thrombosis; 240 are open to participants now.
This study's planned enrollment of 60 is below the median of 212 across 591 observational studies indexed under Thrombosis.
Browse Thrombosis studies →Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
patients admitted to Assiut University hospitals
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All patients are going to be examined by color Doppler ultrasound and the high risk patients are going to be examined by direct MDCT venography .
Also known as: direct MDCT venography
detection of asymptomatic venous thrombosis
silent venous thrombosis in gynecological patients with pelvic masses
Time frame: one week before operation
No study locations are listed for this record.
Start is estimated for Sep 2017; primary completion for Sep 2020, 36 months later.
Of 243 non-industry observational studies under Thrombosis, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 107. This study's planned 36 months is below that.
Counting every sponsor, half of 267 studies reached it within 42 months; a quarter within 19 and three quarters within 99.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.